Profil bibliographique

F. Madore

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

34Publications signalées

1462Citations signalées

1Affiliations récentes

Institutions déclarées

University of Oxford

Domaines associés

Chronic Kidney Disease and DiabetesDiabetes Treatment and ManagementKidney Stones and Urolithiasis TreatmentsRenal function and acid-base balanceDialysis and Renal Disease Management

Publications récentes

Accès ouvert 2023 articleOpenAlex

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne, Christoph Wanner et autres

121 citationsThe Lancet Diabetes & Endocrinology

Accès ouvert 2023 articleOpenAlex

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge, Christoph Wanner et autres

98 citationsThe Lancet Diabetes & Endocrinology

Accès ouvert 2021 articleOpenAlex

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus, Bergur V. Stefánsson et autres

95 citationsKidney International

Accès ouvert 2021 articleOpenAlex

POS-271 COMPARISON OF CENTRAL BLOOD PRESSURE CALIBRATION METHOD AND CARDIOVASCULAR RISK PREDICTION, A PROSPECTIVE STUDY

Florence Lamarche, Mohsen Agharazii, Siegfried Wassertheurer, Heike Bernhard et autres

0 citationsKidney International Reports

Accès ouvert 2021 articleOpenAlex

POS-296 CARDIOVASCULAR RISK PREDICTION WITH AORTIC PULSE WAVE VELOCITY: A CARTAGENE STUDY

S. Veillette, Florence Lamarche, Mohsen Agharazii, Siegfried Wassertheurer et autres

0 citationsKidney International Reports

Accès ouvert 2021 articleOpenAlex

POS-368 DOES NT-PROBNP VARIABILITY PREDICT RENAL AND CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH CKD STAGE G4-5?

Cyril Charron, S. Troyanov, Josée Bouchard, F. Madore et autres

0 citationsKidney International Reports

Accès ouvert 2021 articleOpenAlex

POS-491 A NEW VISION FOR NEPHROLOGY TRIALS IN CANADA

Amanda Murdoch, F. Madore, Dwight Sparkes, Karthik Tennankore et autres

0 citationsKidney International Reports

Accès ouvert 2021 articleOpenAlex

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs, Glenn M. Chertow et autres

122 citationsEuropean Heart Journal

Accès ouvert 2019 conference-abstractOpenAlex

SUN-312 HEALTHY DIET SCORE AND KIDNEY FUNCTION: A CROSS-SECTIONAL ANALYSIS

Dominique S. Genest, Mitra Khalili, Rémi Goupil, Amélie Bernier-Jean et autres

0 citationsKidney International Reports

2019 articleOpenAlex

PERIPHERAL AND CENTRAL ARTERIAL PARAMETERS, BONE DENSITY AND FRACTURES

Louis‐Charles Desbiens, Rémi Goupil, F. Madore, Mohsen Agharazii et autres

1 citationJournal of Hypertension

2019 articleOpenAlex

Fracture status in middle-aged individuals with early CKD: cross-sectional analysis of the CARTaGENE survey

Louis‐Charles Desbiens, Rémi Goupil, Aboubacar Sidibé, F. Madore et autres

5 citationsOsteoporosis International

2018 conference-abstractOpenAlex

URINARY UROMODULIN IN A PATHWAY BETWEEN DECREASED URINARY URIC ACID EXCRETION AND ALBUMINURIA

Alena Krajčoviechová, François-Christophe Marois-Blanchet, S. Troyanov, François Harvey et autres

0 citationsJournal of Hypertension

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.